These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19650211)

  • 21. Words of wisdom. Re: Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?
    Türkeri L
    Eur Urol; 2009 Apr; 55(4):993. PubMed ID: 19650214
    [No Abstract]   [Full Text] [Related]  

  • 22. Words of wisdom. Re: Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?
    Minervini A; Serni S; Carini M
    Eur Urol; 2009 Oct; 56(4):740-1. PubMed ID: 19995522
    [No Abstract]   [Full Text] [Related]  

  • 23. Words of wisdom. Re: Temporary balloon occlusion of the inferior vena cava in resection of renal tumor with vena cava thrombus extension.
    Shirodkar SP; Ciancio G; Gallucci M; Soloway MS
    Eur Urol; 2009 Nov; 56(5):883-4. PubMed ID: 20965033
    [No Abstract]   [Full Text] [Related]  

  • 24. Nephron sparing surgery for renal cell carcinoma 4 cm. or less in diameter: indicated or under treated?
    Wunderlich H; Reichelt O; Schumann S; Schlichter A; Kosmehl H; Werner W; Vollandt R; Schubert J
    J Urol; 1998 May; 159(5):1465-9. PubMed ID: 9554334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Words of wisdom. Re: Abiraterone and increased survival in metastatic prostate cancer.
    Richie JP
    Eur Urol; 2011 Oct; 60(4):871. PubMed ID: 21878199
    [No Abstract]   [Full Text] [Related]  

  • 26. Words of wisdom. Re: Abiraterone and increased survival in metastatic prostate cancer.
    Cheetham PJ; Petrylak DP
    Eur Urol; 2012 Apr; 61(4):850. PubMed ID: 22373884
    [No Abstract]   [Full Text] [Related]  

  • 27. Words of wisdom: Re: Abiraterone in metastatic prostate cancer without previous chemotherapy.
    Di Lorenzo G; Buonerba C
    Eur Urol; 2013 May; 63(5):961. PubMed ID: 23541254
    [No Abstract]   [Full Text] [Related]  

  • 28. Words of wisdom. Re: Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomized open-label trial.
    Jocham D; Sommerauer M
    Eur Urol; 2011 Apr; 59(4):659. PubMed ID: 21414888
    [No Abstract]   [Full Text] [Related]  

  • 29. Words of wisdom. Re: Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.
    Beuzeboc P
    Eur Urol; 2011 Apr; 59(4):658. PubMed ID: 21414886
    [No Abstract]   [Full Text] [Related]  

  • 30. Words of wisdom. Re: use of androgen deprivation therapy for metastatic prostate cancer in older men.
    Daneshmand S
    Eur Urol; 2008 Nov; 54(5):1201-2. PubMed ID: 19051382
    [No Abstract]   [Full Text] [Related]  

  • 31. [Carcinoma and oncocytoma of the kidney. Phenotypic characteristics and prognostic features].
    Störkel S
    Veroff Pathol; 1993; 140():1-165. PubMed ID: 8434485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Words of wisdom. Re: copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.
    Marks LS; Huang J
    Eur Urol; 2010 Apr; 57(4):727-8. PubMed ID: 20965042
    [No Abstract]   [Full Text] [Related]  

  • 33. Words of wisdom. Re: Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.
    Flanigan RC; Polcari A
    Eur Urol; 2009 Apr; 55(4):990-1. PubMed ID: 19650236
    [No Abstract]   [Full Text] [Related]  

  • 34. Pax-2 expression in adult renal tumors.
    Daniel L; Lechevallier E; Giorgi R; Sichez H; Zattara-Cannoni H; Figarella-Branger D; Coulange C
    Hum Pathol; 2001 Mar; 32(3):282-7. PubMed ID: 11274636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Words of wisdom: Re: Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma?
    Terrone C
    Eur Urol; 2012 Jun; 61(6):1267-8. PubMed ID: 22542093
    [No Abstract]   [Full Text] [Related]  

  • 36. Lower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of renal clear cell carcinoma.
    Deng Q; Wang Z; Wang L; Zhang L; Xiang X; Wang Z; Chong T
    Jpn J Clin Oncol; 2013 Dec; 43(12):1261-8. PubMed ID: 24186908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Words of wisdom. Re: enucleation of renal cell carcinoma with ablation of the tumour base.
    Minervini A; Lanzi F; Carini M
    Eur Urol; 2008 Dec; 54(6):1442-3. PubMed ID: 19189438
    [No Abstract]   [Full Text] [Related]  

  • 38. Reply to Kazutaka Saito's Words of Wisdom re: Nephron-sparing Techniques Independently Decrease the Risk of Cardiovascular Events Relative to Radical Nephrectomy in Patients with a T1a-T1b Renal Mass and Normal Preoperative Renal Function. Eur Urol. 2016;69:538.
    Capitanio U; Dell'Oglio P; Larcher A; Montorsi F
    Eur Urol; 2016 Nov; 70(5):e135. PubMed ID: 27131952
    [No Abstract]   [Full Text] [Related]  

  • 39. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Words of Wisdom. Re: Vinflunine in Routine Clinical Practice for the Treatment of Advanced or Metastatic Urothelial Cell Carcinoma--Data from a Prospective, Multicenter Experience.
    Soave A; Rink M
    Eur Urol; 2016 Feb; 69(2):373-4. PubMed ID: 26758521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.